Group
OpenWho we are
OpenGovernance
OpenWhat we do
OpenOur strategy
OpenInnovation
OpenResearch & Development
OpenGlobal markets & Technologies
OpenSustainable development
OpenGroup fundamentals
OpenExtra financial regulations
OpenIndustry
OpenMarkets
OpenProcesses
OpenDiseases
OpenPublic health challenges
OpenElectronics
OpenEngineering & Construction
OpenScience & New energies
OpenLarge projects
Open
Scientific expertise
R&D is relying on science to build the future. Thanks to a strong expertise on Essential Small Molecules and its knowledge on data science, R&D has a wide range of competencies in:
- material sciences
- process engineering
- life sciences
- chemistry
- combustion
- cryogenics
- analytical sciences
With its 200 scientific and industrial partners, R&D is actively working to enrich its knowledge of Small Essential Molecules to explore new horizons and thus provide solutions to the industry's future challenges.
Our 18 essential molecules are: oxygen (O2), nitrogen (N2), hydrogen (H2), carbon dioxide (CO2), carbon monoxide (CO), methane (CH4), argon (Ar), xenon (Xe), krypton (Kr), neon (Ne), helium (He), nitric oxide (NO), nitrogen dioxide (N2O), acetylene (C2H2), ozone (O3), water (H2O), silane (SiH4).
The innovation Campuses
With 5 Innovation Campuses located on 3 continents, the R&D is well connected with key innovation ecosystems. It allows global management with local anchoring to adapt to the needs of our customers, for example, in Asia with laser-cutting, in the US with data science and cobotics, and in Europe with hydrogen mobility business and the technological roadmap.
The campuses host researchers, customers, business partners, start-up companies, and academics but also technical teams from other Air Liquide entities. The one in Paris even hosts a start-up accelerator called: Accelair.
They bring together all parties involved in the process of innovation, from both inside and outside Air Liquide, to blend skills and disciplines, facilitate collective intelligence, and accelerate the innovation.
The R&D anticipates and meets the societal challenges and needs of its clients.
R&D innovates for the energy and environmental transitions.
55% of R&D project spend linked to the energy & environmental transitions.
- CO2 capture. The combustion step liberates CO2 molecules in the atmosphere. To reduce these emissions, our teams developed technologies enabling them to capture and store this CO2. We allow, at last, after chemical transformation to use these CO2 molecules again. We convert them into basic chemicals such as Olefins and Methanol.
R&D aims to ensure scientific excellence, leadership and skills in the fields of Data Science (AI, machine learning) and Decision Sciences (operations research, financial mathematics, game theory).
30% of all R&D projects apply digital in the scientific workflow (automated procedures for data handling, advanced physical & data-driven modeling...).
- Digitalization of decision. The success of customer experience is at the heart of our performance. It has to be efficient, simple and customized. Our teams developed a tool that provides dispatch analytics and models of customer demands using data science. The tool enables us to provide extra-volumes of gases to our customers at specific times at the best prices.
R&D is involved throughout the healthcare pathway, from the hospital to the home, in order to develop new product and service offers for healthcare professionals and patients.
- E-health for chronic patients. Improving the quality of life and care of patients at home is a significant global challenge, both socially and technologically. To contribute to this effort, R&D teams have rolled out a remote medical surveillance solution improving the home monitoring of patients with chronic diseases. This monitoring relies on the analysis of data transmitted by individualized connected medical devices.
